Skip to content

Clinical trials

Completed Alzheimer Disease trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Chile Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20071
20083
20093
20101
20131
20141
20152
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Eli Lilly and Company2
H. Lundbeck A/S2
ACADIA Pharmaceuticals Inc.1
Axovant Sciences Ltd.1
Forest Laboratories1
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Dementia3
Brain Diseases1
Corticobasal Degeneration1
Dementia, Vascular1
Hallucinations1
Lewy Body Disease1
Lymphoma, Follicular1
Psychotic Disorders1
Supranuclear Palsy, Progressive1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.